Phenylalanyl-tRNA synthetases [L-phenylal-anine:tRNAPb ligase (AMP-forming), EC 6.1. An ac22 structure was proposed, too, for the yeast mitochondrial phenylalanyl-tRNA synthetase, which has a molecular weight and subunit sizes very close to those of its cytoplasmic counterpart (17). Recently, the gene MSFI encoding the mitochondrial a subunit was isolated and sequenced (18). Despite considerable sequence divergence between the mitochondrial and cytoplasmic phenylalanyltRNA synthetases as far as the a subunit is concerned, their striking similarity in size was taken into consideration to examine the possibility that the mitochondrial a subunit could combine with the cytoplasmic ,B subunit to build up a functional chimera. To test this idea, we created an operon with the corresponding MSFI and FRSI structural genes, using the E. coli pheST intergenic region (15) to produce a polycistronic mRNA. A construction with the MSFI gene alone fused to the lacZ gene was used as a control, assuming that an isolated mitochondrial subunit would be inactive, as is the case for individual subunits of the yeast and E. coli phenylalanine enzymes. To our surprise the MSF1 protein by itself was found to be active. We purified the MSF1 protein and measured its catalytic properties. Turnover rates in the aminoacylation reaction were found to be comparable to those of monomeric or oligomeric aminoacyl-tRNA synthetases. Similarly, the same fully active monomeric protein was obtained when the MSF1 protein was expressed from the MSFI-FRSJ operon, indicating that no heterologous association of the mitochondrial and cytoplasmic subunits had occurred. Therefore, we focused our attention on the quaternary structure and tRNA specificity of the MSF1 protein; the data reported here support the model of a monomeric mitochondrial phenylalanyl-tRNA synthetase.
(a2Z32) tRNA synthetases (2, 3) occur, respectively, as monomeric (4) and dimeric (5) forms in yeast (Saccharomyces cerevisiae). However, it is not excluded that these forms may have arisen through uncontrolled proteolysis during the course of their purification. A third example, the transition of methionyl-tRNA synthetase from dimer (Escherichia coli) to monomer (yeast cytoplasmic or mitochondrial), could be confirmed at the molecular level. It arose by the loss of a dimerization domain at the C terminus of the yeast enzymes and reflects a situation that could be obtained in vitro by mild proteolysis of the dimeric E. coli enzyme (6) . It results in a monomeric active fragment whose C terminus coincides with that of the native yeast cytoplasmic and mitochondrial methionyl-tRNA synthetases (7, 8) . The conservation of quaternary structure is particularly exemplified in the case of phenylalanyl-tRNA synthetase [L-phenylalanine:tRNAI'e ligase (AMP-forming), EC 6.1. 1.20] , which occurs as a tetramer of the a2f32 type in E. coli (9) , Bacillus subtilis (10), yeast cytoplasm (11) , and mammalian cytoplasm (12, 13) . All these forms have a similar molecular weight in the range of 250,000.
However, the molecular weights for the large (13; Mr, 87, 000) and small (a; Mr, 37,000) subunits of E. coli phenylalanyltRNA synthetase (9) differ markedly from those determined for the corresponding enzyme from yeast cytoplasm [respectively, 70 ,000 and 60,000t (5) ]. The genes coding for the a and ,1 subunits have been cloned and sequenced in the case of the E. coli (14, 15) and yeast (16) cytoplasmic phenylalanyl-tRNA synthetases. Sequence comparisons did not show any strong homology between individual subunits and excluded the possibility that the dissimilarity in subunit sizes between E. coli and yeast could have arisen through intramolecular rearrangements (16) .
An ac22 structure was proposed, too, for the yeast mitochondrial phenylalanyl-tRNA synthetase, which has a molecular weight and subunit sizes very close to those of its cytoplasmic counterpart (17) . Recently, the gene MSFI encoding the mitochondrial a subunit was isolated and sequenced (18) . Despite considerable sequence divergence between the mitochondrial and cytoplasmic phenylalanyltRNA synthetases as far as the a subunit is concerned, their striking similarity in size was taken into consideration to examine the possibility that the mitochondrial a subunit could combine with the cytoplasmic ,B subunit to build up a functional chimera. To test this idea, we created an operon with the corresponding MSFI and FRSI structural genes, using the E. coli pheST intergenic region (15) to produce a polycistronic mRNA. A construction with the MSFI gene alone fused to the lacZ gene was used as a control, assuming that an isolated mitochondrial subunit would be inactive, as is the case for individual subunits of the yeast and E. coli phenylalanine enzymes. To our surprise the MSF1 protein by itself was found to be active. We purified the MSF1 protein and measured its catalytic properties. Turnover rates in the aminoacylation reaction were found to be comparable to those of monomeric or oligomeric aminoacyl-tRNA synthetases. Similarly, the same fully active monomeric protein was obtained when the MSF1 protein was expressed from the MSFI-FRSJ operon, indicating that no heterologous association of the mitochondrial and cytoplasmic subunits had occurred. Therefore, we focused our attention on the quaternary structure and tRNA specificity of the MSF1 protein; the data reported here support the model of a monomeric mitochondrial phenylalanyl-tRNA synthetase.
MATERIALS AND METHODS lacZ-MSFI Gene Fusion. MSFJ was fused to lacZ by using procedures and vectors similar to those used in the construction of the phenylalanyl-tRNA synthetase operon (19) . Plasmid pG120/ST10 (18) 15 JuM tRNAPhI (cytoplasmic), and 67 nM enzyme; Km for tRNAPhe, 0.8-40 AM tRNAPhI, 2 mM ATP, 100 AM phenylalanine (320 cpm/pmol), and 22 nM enzyme. kcat/Km was also measured by using unfractionated mitochondrial tRNA from the kinetics obtained with 6.2 and 12.5 ,uM tRNA (tRNAPhe is 2.5% of total tRNA). The data with the cytoplasmic enzyme are taken from our previous published results (21 Ultrogel column (3.5 cm x 11 cm; HA Ultrogel). Elution was with a 50-500 mM linear phosphate gradient.
RESULTS
Expression of the MSF1 Protein in E. col. The MSFI gene was fused with lacZ to produce a fusion protein with 16 extra amino acid residues from (-galactosidase. Fig. 1 summarizes the steps in the construction. The plasmid derivative of M13-AS3MSF1 construct was obtained by subcloning the Xba I-Kpn I fragment in pUC19. This plasmid was used to transform E. coli cells, and the activity was tested with yeast cytoplasmic tRNAI'h (Fig. 2) . Cytoplasmic yeast tRNAPme was previously shown to be a good substrate for aminoacylation by the mitochondrial phenylalanine enzyme (20) , and it allows discrimination of the endogenous E. coli phenylalanyl-tRNA synthetase activity (ref. 19 and Fig. 2 and had a specific activity of 900 units/mg. We conducted an
equilibrium sedimentation experiment to confirm the low molecular weight of the MSF1 protein, using the meniscus depletion method with schlieren optics. A molecular weight of 56,800 was calculated from a 24-hr sedimentation run at 25,000 rpm. The molecular weight determinations of the MSF1 protein in the native and NaDodSO4-denatured state indicate that the protein is monomeric. The discrepancy in molecular weights estimated by gel filtration versus sedimentation and polyacrylamide gel electrophoresis in the presence of NaDodSO4 was also noted for other aminoacyl-tRNA synthetases purified in the laboratory and may result from retardation effects due to hydrophobic or hydrophilic interactions with the gel matrix.
Because the MSF1 protein was expressed in E. coli, we wished to rule out the possibility that the observed activity results from an association with the /3 subunit of the E. coli phenylalanyl-tRNA synthetase. A priori, this hypothesis is unlikely, because the increase in specific activity follows the purification state of the protein. We could definitely rule out any contamination (or association) by Western blot experiments showing the absence of cross-reaction between the MSF1 protein and polyclonal antibodies raised against the E. coli phenylalanyl-tRNA synthetase (or,/-specific antibodies; results not shown). All these results indicate that the MSF1 protein is active by itself.
N-Terminal Sequence Analysis of the MSF1 Protein Expressed by E. coli. To confirm that the purified protein is the MSFJ gene product, we sequenced the N terminus by Edman degradation using an automatic gas-phase sequencer. Analyses revealed that two amino acids were simultaneously liberated at each step in equimolar amounts. However, the residues could easily be assigned with the help of the genederived sequence. They corresponded to the peptide region 11-17 and 21-27 of the N terminus (Fig. 4) , indicating that internal proteolysis has removed the portion of the /3-galac- the ATP-PPj exchange or tRNA aminoacylation. This has been particularly well documented for the bacterial glycyland phenylalanyl-tRNA synthetases and the yeast cytoplasmic phenylalanyl-tRNA synthetase, although a dissimilar tRNA binding site distribution was noted. Much of the interaction with the tRNA appears to be confined to the (3 subunit of the E. coli glycine and phenylalanine enzymes (3, 22, 23) and to the a subunit in the case of the yeast cytoplasmic phenylalanyl-tRNA synthetase (24) . The combination of the two subunits to form an active species strongly suggests that the active site is at the subunit interface. It is shown here that the MSF1 protein, a mitochondrial a-subunit-like monomer of474 residues, charges yeast cytoplasmic tRNAlhc with a high turnover number (kcat value in the range of 1 s51, Table 1 
CONSENSUS
-I---P---DXIA-V- (2) . The full-length protein of 875 residues per subunit can be progressively shortened into a catalytic domain of 461 residues. This fragment is a monomer and contains an independent N-terminal activation domain of 368 amino acids to which the addition of 93 residues at the C terminus is necessary for tRNA binding and aminoacylation (27) . It was also demonstrated for glycyl-tRNA synthetase that the two subunits need not be organized in a tetrameric a2(32 structure to generate activity: when the genes encoding the a and (3 subunits were fused, the resulting (a-18)2 dimer retained 10%6
of the aminoacylation activity (28) . Activities comparable to the activity of the wild-type enzyme are achieved only in the unfused derivative, providing a catalytic advantage to the oligomeric a2A2 structure. Such an advantage seems to be lost for the mitochondrial phenylalanyl-tRNA synthetase, since the MSF1 protein has a turnover rate that resembles that of the cytoplasmic isoenzyme. A plausible role for a second subunit would be to improve tRNA specificity by providing negative interactions with noncognate tRNAs. The discovery that the mitochondrial henylalanyl-tRNA synthetase can efficiently charge tRNA as a single polypeptide chain raises some questions from a functional and evolutionary point ofview. A closer sequence resemblance of the MSF1 protein with the E. coli a subunit (16) suggested that the MSFJ ancestral gene was most probably prokaryotic. One possibility is that the mitochondrial phenylalanine enzyme evolved from the E. coli subunit (a = 327 residues) by insertion of a polypeptide of approximately 60 amino acid residues and an extension of 109 residues at the C terminus (Fig. 5) . Experimental evidence for a functional role of the C-terminal stretch comes from the loss of the mitochondrial phenylalanyl-tRNA synthetase activity when a deletion in the MSFJ gene removes 94 amino acid residues from the C terminus (18) . This result supports the idea that functional regions are conserved between the MSF1 insertions and the yeast or bacterial (3 subunits. After extended computer analysis, no significant homology could be identified with the yeast cytoplasmic protein. However, there is considerable sequence identity (30%6) between the C terminus ofMSF1 and that of the ,3 subunits from E. coli and B. subtilis (Fig. 6 ). The lack of homology with the cytoplasmic sequences is not clearly understood. It may reflect a greater sequence divergence compared with the prokaryotic sequences. The "primitive" MSF1 protein has the three sequence motifs that characterize the recently defined class II of aminoacyl-tRNA synthetases (29, 30 (33) . A profile generated by the alignment of the two sequences from E. coli (FRSTEC) and B. subtilis (FRSBBS) was used to screen the complete protein data base Swiss-Prot. The C-terminal extension of the MSF1 protein was the only additional sequence found with a significant score (33) . cleotide-binding fold that interacts with ATP in class I enzymes. Instead, motif 3, which is composed of two antiparallel 3 strands connected by a disordered loop in seryltRNA synthetase, is thought to participate in the active site (30) .
One particularity of the mitochondrial phenylalanyl-tRNA synthetase is that it charges both mitochondrial and nonmitochondrial tRNA""e [yeast cytoplasmic or E. coli (20) ], and this is also true for the MSF1 protein (see Table 1 ). Both yeast cytoplasmic and E. coli phenylalanyl-tRNA synthetases make contacts with discriminatory bases in tRNAPII that are located in three topologically distinct single-stranded regions, the D and anticodon loops and the ACCA-end, implying a large covering of the tRNA by the pseudodimeric phenylalanyl-tRNA synthetases (31, 32) . The MSFI protein, which is much smaller, probably interacts with the tRNA in a simpler or different mode. Determination of the nucleotide sites that specify tRNAmhC identity and analysis of the topology of the MSF1tRNAI' complex may reveal the particular features in tRNA recognition by the MSF1 protein.
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